Supply Chain Intelligence

Atara Biotherapeutics, Inc. Supply Chain

ATRA supply chain intelligence for Atara Biotherapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

ATRA ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

2Suppliers
3Customers
2Debt Items
20Related Chains

Atara Biotherapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
PIERRE-FABRE-MEDICAMENT PIERRE-FABRE-MEDICAMENT 90% Agreement dated October 31, 2023 with Pierre Fabre Medicament, as amended, from June 30, 2026 to January 1, 2028
CRBU Caribou Biosciences, Inc. 72% Reciprocal relationship from CRBU graph: untries where our product candidates may be sold at lower prices than in the United States. Third-party payors, whether domestic or foreign, governmental or c…

Atara Biotherapeutics, Inc. Customers

TickerNameConfidenceEvidence
PIERRE-FABRE PIERRE-FABRE 90% In March 2025, in connection with the transition of manufacturing responsibility for tab-cel to Pierre Fabre, we assigned the Fujifilm MSA to Pierre Fabre.
PIERRE-FABRE-MEDICAMENT PIERRE-FABRE-MEDICAMENT 90% Under the terms of the Amendment, the Company has agreed to reduce the aggregate amount of potential milestone payments payable by Pierre Fabre to the Company upon achieving certain regulatory milest…
CRBU Caribou Biosciences, Inc. 72% Reciprocal relationship from CRBU graph: untries where our product candidates may be sold at lower prices than in the United States. Third-party payors, whether domestic or foreign, governmental or c…

Atara Biotherapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ATRA-DEBT-7955 Xbrl Convertible 90% xbrl convertible detail from xbrl 2014-12-31.
ATRA-DEBT Debt stack $9.1M 90% Market cache reports total debt of $9.1M.

Atara Biotherapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Atara Biotherapeutics, Inc..

Atara Biotherapeutics, Inc. Ownership

HolderNameConfidenceEvidence
ATRA-OWNER-ADAGE-CAPITAL-PARTNERS-GP-L-L-C ADAGE CAPITAL PARTNERS GP, L.L.C. 90% 13F overlay lists ADAGE CAPITAL PARTNERS GP, L.L.C. as top holder; 35 tracked holders.

Atara Biotherapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
TRIB Trinity Biotech plc 100.00 2
ABBV AbbVie Inc. 100.00 2
CLGN CollPlant Biotechnologies Ltd. 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
CRSP CRISPR Therapeutics AG 100.00 2
BLLN BillionToOne, Inc. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
CRBU Caribou Biosciences, Inc. 100.00 1 ['customer', 'supplier']
CYTOF Altamira Therapeutics Ltd. 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
DTIL Precision BioSciences, Inc. 100.00 2
ADGM Adagio Medical Holdings, Inc. 100.00 2
CSTE Caesarstone Ltd. 100.00 2
AORT Artivion, Inc. 100.00 2
SNNUF Smith & Nephew plc 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
ALC Alcon Inc. 100.00 2
ACIU AC Immune SA 100.00 2
View ATRA supply chain intel →

Explore the full interactive supply chain map for Atara Biotherapeutics, Inc..

Open ATRA supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map